{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:10:15Z","timestamp":1760836215378,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.bmc.2017.12.009","type":"journal-article","created":{"date-parts":[[2017,12,9]],"date-time":"2017-12-09T04:43:18Z","timestamp":1512794598000},"page":"977-983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development and optimization of a new synthetic process for lorcaserin"],"prefix":"10.1016","volume":"26","author":[{"given":"J\u00e9r\u00f4me","family":"Cluzeau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaj","family":"Stavber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2017.12.009_b0005","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1021\/jm0709034","article-title":"Discovery and structure\u2212activity relationship of (1R)-8-Chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a selective serotonin 5-HT2C receptor agonist for the treatment of obesity","volume":"51","author":"Smith","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.12.009_b0010","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ijo.2014.169","article-title":"The uphill battle facing anti-obesity drugs","volume":"39","author":"Daubresse","year":"2015","journal-title":"Int J Obesity"},{"key":"10.1016\/j.bmc.2017.12.009_b0015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/2040622314522848","article-title":"Pharmacotherapy for obesity: novel agents and paradigms","volume":"5","author":"Manning","year":"2014","journal-title":"Therap Adv Chronic Dis"},{"key":"10.1016\/j.bmc.2017.12.009_b0020","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.bmcl.2004.12.080","article-title":"Discovery and SAR of new benzazepines as potent and selective 5-HT2C receptor agonists for the treatment of obesity","volume":"15","author":"Smith","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2017.12.009_b0025","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1021\/acs.oprd.5b00144","article-title":"Novel synthesis of antiobesity drug lorcaserin hydrochloride","volume":"19","author":"Zhu","year":"2015","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.bmc.2017.12.009_b0030","unstructured":"Burbaum BW, Gilson CA, Aytes S, Estrada SA, Sengupta D, Smith B, Rey M, Weigl U. Process for preparation of 3-benzazepines. WO Patent P.N.:2005019179."},{"key":"10.1016\/j.bmc.2017.12.009_b0035","unstructured":"Weigl U, Porstmann F, Straessler C, Ulmer L, Koetz U. Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrhydro-1H-3-benzazepine and intermediates related thereto. WO Patent P.N.:2007120517."},{"key":"10.1016\/j.bmc.2017.12.009_b0040","unstructured":"Gharbaoui T, Tandel SK, Ma Y, Carlos M, Fritch JR. Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrhydro-1H-3-benzazepine and intermediates thereof. WO Patent P.N.:2008070111."},{"key":"10.1016\/j.bmc.2017.12.009_b0045","unstructured":"Demattel J, Carlos M, Castro R, Chuang T-H, Hadd M, Lu X-X, Macias M, Shaw SM, Processes for the preparation of 5-HT 2C receptor agonists. WO patent P.N.:2010148207."},{"key":"10.1016\/j.bmc.2017.12.009_b0050","unstructured":"Carlos M, Castro R, Ghar-Baoui T, Lu X-X, Ma Y-A, San Martin N. Processes for the preparation of intermediates related to the HT2c agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine. WO patent P.N. 2009111004."},{"key":"10.1016\/j.bmc.2017.12.009_b0055","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3762\/bjoc.7.49","article-title":"The preparation of 3-substituted-1,5-dibromopentanes as precursors to heteracyclohexanes","volume":"7","author":"Ringstrand","year":"2011","journal-title":"Beilstein J Org Chem"},{"key":"10.1016\/j.bmc.2017.12.009_b0060","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1248\/cpb.33.3775","article-title":"Studies on 2 (1H)-quinolinone derivatives as gastric antiulcer active agents. 2-(4-chlorobenzoylamino)-3-[2 (1H)-quinolinon-4-yl] propionic acid and related compounds","volume":"33","author":"Uchida","year":"1985","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.bmc.2017.12.009_b0065","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1021\/jo01298a049","article-title":"Friedel-crafts cyclization of chloro-substituted (benzy1amino)propyl bromides. formation of 4-methyltetrahydroisoquinoline","volume":"45","author":"Perchonock","year":"1980","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2017.12.009_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3762\/bjoc.6.6","article-title":"A review of new developments in the Friedel-Crafts alkylation \u2013 from green chemistry to asymmetric catalysis","volume":"6","author":"Rueping","year":"2010","journal-title":"Beilstein J Org Chem"},{"key":"10.1016\/j.bmc.2017.12.009_b0075","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1021\/acs.orglett.6b02492","article-title":"Room temperature catalyst system for the hydroarylation of olefins","volume":"18","author":"Lee","year":"2016","journal-title":"Org Lett"},{"key":"10.1016\/j.bmc.2017.12.009_b0080","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cej.2015.08.008","article-title":"Modelling chemical kinetics of a complex reaction network of active pharmaceutical ingredient (API) synthesis with process optimization for benzazepine heterocyclic compound","volume":"283","author":"Grom","year":"2016","journal-title":"Chem Eng J"},{"key":"10.1016\/j.bmc.2017.12.009_b0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molcata.2014.11.020","article-title":"Effects of catalyst composition on the ionic liquid catalyzed isobutane\/2-butene alkylation","volume":"398","author":"Liu","year":"2015","journal-title":"J Mol Cat A: Chem"},{"key":"10.1016\/j.bmc.2017.12.009_b0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.apcata.2004.08.019","article-title":"Effects of additives on the properties of chloroaluminate ionic liquids catalyst for alkylation of isobutane and butene","volume":"277","author":"Huang","year":"2004","journal-title":"App Cat A: Gen"},{"key":"10.1016\/j.bmc.2017.12.009_b0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40508-016-0051-z","article-title":"Tools and techniques for solvent selection: green solvent selection guides","volume":"4","author":"Byrne","year":"2016","journal-title":"Sustain Chem Process"},{"key":"10.1016\/j.bmc.2017.12.009_b0100","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1021\/op060158p","article-title":"DMSO can be more than a solvent: thermal analysis of its chemical interactions with certain chemicals at different process stages","volume":"10","author":"Bollyn","year":"2006","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.bmc.2017.12.009_b0105","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1021\/op300016m","article-title":"Safety concerns in a pharmaceutical manufacturing process using dimethyl sulfoxide (DMSO) as a solvent","volume":"16","author":"Wang","year":"2012","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.bmc.2017.12.009_b0110","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1021\/op500260n","article-title":"Safe scale-up of pharmaceutical manufacturing processes with dimethyl sulfoxide as the solvent and a reactant or a byproduct","volume":"18","author":"Wang","year":"2014","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.bmc.2017.12.009_b0115","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1021\/op600275g","article-title":"Development of a scalable process for the synthesis of trans-2-methylcyclopropanecarboxylic acid","volume":"11","author":"Delhaye","year":"2007","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.bmc.2017.12.009_b0120","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1021\/op300077m","article-title":"Identification, synthesis, and strategy for minimization of potential impurities observed in Raltegravir potassium drug substance","volume":"16","author":"Patil","year":"2012","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.bmc.2017.12.009_b0125","first-page":"73180","article-title":"Practical access to 1,3,5-triarylbenzenes from chalcones and DMSO","volume":"5","author":"Wang","year":"2015","journal-title":"RCS Adv"},{"key":"10.1016\/j.bmc.2017.12.009_b0130","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1021\/op7002584","article-title":"Route scouting and process development of LU AA26778","volume":"12","author":"Dahl","year":"2008","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.bmc.2017.12.009_b0135","first-page":"9","article-title":"Hazards involved in the handling and use of Dimethyl Sulphoxide DMSO","volume":"114","year":"1993","journal-title":"Loss Prev Bull"},{"key":"10.1016\/j.bmc.2017.12.009_b0140","first-page":"269","volume":"23","author":"Itoh","year":"1984","journal-title":"Anzen Kogaku"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808961731814X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808961731814X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:53:48Z","timestamp":1760835228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096808961731814X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S096808961731814X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2017.12.009","relation":{},"ISSN":["0968-0896"],"issn-type":[{"type":"print","value":"0968-0896"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and optimization of a new synthetic process for lorcaserin","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2017.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}